Emily Rundlet

Title: Emily Rundlet: Innovator in Respiratory Syncytial Virus Research

Introduction

Emily Rundlet is a prominent inventor based in New York, NY, who has made significant contributions to the field of virology. She holds three patents, showcasing her innovative work in developing treatments for respiratory infections. Her research primarily focuses on the Respiratory Syncytial Virus (RSV), a major cause of respiratory illness in infants and young children.

Latest Patents

One of Emily Rundlet's latest patents involves the development of prefusion RSV F proteins and their use. This patent describes embodiments of a recombinant RSV F ectodomain trimer that is stabilized in a prefusion conformation. The patent also discloses nucleic acids encoding the RSV F ectodomain trimer and methods for producing it. Furthermore, it outlines methods for inducing an immune response in a subject, which can be utilized for treating or preventing RSV infections by administering a therapeutically effective amount of the recombinant RSV F ectodomain trimer.

Career Highlights

Emily Rundlet is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to focus on groundbreaking research that has the potential to impact public health significantly.

Collaborations

Throughout her career, Emily has collaborated with notable scientists such as Peter D. Kwong and Barney S. Graham. These collaborations have further enhanced her research and contributed to the advancement of knowledge in the field of virology.

Conclusion

Emily Rundlet is a dedicated inventor whose work in RSV research is paving the way for new therapeutic approaches. Her innovative patents and collaborations highlight her commitment to improving health outcomes for vulnerable populations.